Trevena Added to Russell 2000®, Russell 3000®, and Russell Microcap® Indexes

NEXT STORY
Crinetics Pharmaceuticals Announces Dosing of First Patient in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly
PREV STORY
Kymera Therapeutics Announces Positive Interim Results from Single Ascending Dose Phase 1 Trial of KT-474 Demonstrating Degrader Proof-of-Mechanism
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Brii Biosciences, Vir Biotechnology and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B

author_avatar
NASDAQ Market News

Sight Sciences Announces FDA Authorization for the PRECISION Trial, a Groundbreaking Three-Arm Randomized, Controlled IDE Trial of Canal Viscodilation in Combination with Cataract Surgery in Adults with Primary Open-Angle Glaucoma (POAG)

author_avatar
NASDAQ Market News

South Western Sydney PHN selects Allscripts dbMotion™ Solution to deliver integrated care

SYDNEY, Australia, Sept. 06, 2017 (GLOBE NEWSWIRE) -- South Western Sydney PHN (SWSPHN) has ...

author_avatar
NASDAQ Market News